Skip to main navigation Skip to search Skip to main content

Artifcial Intelligence for MRI-Based Diagnosis of Prostate Cancer in Clinical Practice

Research output: A Conference proceeding or a Chapter in Book › Chapter › peer-review

Abstract

Advances in machine learning, innovations in imaging hardware, and standardisation of protocols are unfolding the potential of medical imaging as central diagnostic tool for prostate cancer. Beyond the improvement in repeatability, objectivity, and speed that come with automated support, the use of artificial intelligence (AI) opens the way for better diagnostic accuracy by using not only visual features but also a large number of mathematically calculated features that are not obvious to the human eye. Beyond diagnosis, the information provided by those features is relevant also for management of PCa, including prediction of progress, recurrence, and survival. Overall, radiologists have a positive attitude towards the use of AI as support tool, but the impact of AI on PCa assessment in clinical practice has been modest so far. This chapter presents the state of the art and discusses the potential and limitations of the use of AI for MRI-based diagnosis and management of PCa in clinical practice.

Original languageEnglish
Title of host publicationArtifcial Intelligence and Data Analytics in Medical Imaging
EditorsChristopher Hayre, Rob Davidson, Shayne Chau, Xiaoming Zheng, Abel Zhou, Nigel Frame
PublisherCRC Press
Chapter10
Pages207-223
Number of pages17
Edition1
ISBN (Electronic)9781040497517
ISBN (Print)9781032494913
DOIs
Publication statusPublished - 1 Jan 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Artifcial Intelligence for MRI-Based Diagnosis of Prostate Cancer in Clinical Practice'. Together they form a unique fingerprint.

Cite this